Previous Article | Next Article 
Molecular and Cellular Biology, May 1999, p. 3635-3644, Vol. 19, No. 5
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Functional and Physical Interactions between AML1 Proteins and an
ETS Protein, MEF: Implications for the Pathogenesis of
t(8;21)-Positive Leukemias
Shifeng
Mao,1
Richard C.
Frank,1,2
Jin
Zhang,1
Yasushi
Miyazaki,1 and
Stephen
D.
Nimer1,2,*
Laboratory of Molecular Aspects of
Hematopoiesis1 and Division of
Hematologic Oncology,2 Department of Medicine,
Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Received 23 June 1998/Returned for modification 18 August
1998/Accepted 19 February 1999
The AML1 and ETS families of transcription factors play critical
roles in hematopoiesis; AML1, and its non-DNA-binding heterodimer partner CBF
, are essential for the development of definitive hematopoiesis in mice, whereas the absence of certain ETS proteins creates specific defects in lymphopoiesis or myelopoiesis. The promoter
activities of numerous genes expressed in hematopoietic cells are
regulated by AML1 proteins or ETS proteins. MEF (for myeloid ELF-1-like
factor) is a recently cloned ETS family member that, like AML1B, can
strongly transactivate several of these promoters, which led us to
examine whether MEF functionally or physically interacts with AML1
proteins. In this study, we demonstrate direct interactions between MEF
and AML1 proteins, including the AML1/ETO fusion protein, in
t(8;21)-positive acute myeloid leukemia (AML) cells. Using mutational
analysis, we identified a novel ETS-interacting subdomain (EID) in the
C-terminal portion of the Runt homology domain (RHD) in AML1 proteins
and determined that the N-terminal region of MEF was responsible for
its interaction with AML1. MEF and AML1B synergistically transactivated
an interleukin 3 promoter reporter gene construct, yet the activating
activity of MEF was abolished when MEF was coexpressed with AML1/ETO.
The repression by AML1/ETO was independent of DNA binding but depended on its ability to interact with MEF, suggesting that AML1/ETO can
repress genes not normally regulated by AML1 via protein-protein interactions. Interference with MEF function by AML1/ETO may lead to
dysregulation of genes important for myeloid differentiation, thereby
contributing to the pathogenesis of t(8;21) AML.
*
Corresponding author. Mailing address: Memorial
Sloan-Kettering Cancer Center, Box 575, 1275 York Ave., New York, NY
10021. Phone: (212) 639-7871. Fax: (212) 794-5849. E-mail:
s-nimer{at}mskcc.org.
Molecular and Cellular Biology, May 1999, p. 3635-3644, Vol. 19, No. 5
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Huang, H., Yu, M., Akie, T. E., Moran, T. B., Woo, A. J., Tu, N., Waldon, Z., Lin, Y. Y., Steen, H., Cantor, A. B.
(2009). Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development. Mol. Cell. Biol.
29: 4103-4115
[Abstract]
[Full Text]
-
Sashida, G., Liu, Y., Elf, S., Miyata, Y., Ohyashiki, K., Izumi, M., Menendez, S., Nimer, S. D.
(2009). ELF4/MEF Activates MDM2 Expression and Blocks Oncogene-Induced p16 Activation To Promote Transformation. Mol. Cell. Biol.
29: 3687-3699
[Abstract]
[Full Text]
-
Zhao, X., Jankovic, V., Gural, A., Huang, G., Pardanani, A., Menendez, S., Zhang, J., Dunne, R., Xiao, A., Erdjument-Bromage, H., Allis, C. D., Tempst, P., Nimer, S. D.
(2008). Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev.
22: 640-653
[Abstract]
[Full Text]
-
Lin, S., Perl, A.-K. T., Shannon, J. M.
(2006). Erm/Thyroid Transcription Factor 1 Interactions Modulate Surfactant Protein C Transcription. J. Biol. Chem.
281: 16716-16726
[Abstract]
[Full Text]
-
Liu, Y., Hedvat, C. V., Mao, S., Zhu, X.-H., Yao, J., Nguyen, H., Koff, A., Nimer, S. D.
(2006). The ETS Protein MEF Is Regulated by Phosphorylation-Dependent Proteolysis via the Protein-Ubiquitin Ligase SCFSkp2. Mol. Cell. Biol.
26: 3114-3123
[Abstract]
[Full Text]
-
Rainis, L., Toki, T., Pimanda, J. E., Rosenthal, E., Machol, K., Strehl, S., Gottgens, B., Ito, E., Izraeli, S.
(2005). The Proto-Oncogene ERG in Megakaryoblastic Leukemias. Cancer Res.
65: 7596-7602
[Abstract]
[Full Text]
-
Liu, S., Shen, T., Huynh, L., Klisovic, M. I., Rush, L. J., Ford, J. L., Yu, J., Becknell, B., Li, Y., Liu, C., Vukosavljevic, T., Whitman, S. P., Chang, K.-S., Byrd, J. C., Perrotti, D., Plass, C., Marcucci, G.
(2005). Interplay of RUNX1/MTG8 and DNA Methyltransferase 1 in Acute Myeloid Leukemia. Cancer Res.
65: 1277-1284
[Abstract]
[Full Text]
-
Wang, Y.-Y., Zhou, G.-B., Yin, T., Chen, B., Shi, J.-Y., Liang, W.-X., Jin, X.-L., You, J.-H., Yang, G., Shen, Z.-X., Chen, J., Xiong, S.-M., Chen, G.-Q., Xu, F., Liu, Y.-W., Chen, Z., Chen, S.-J.
(2005). AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec. Proc. Natl. Acad. Sci. USA
102: 1104-1109
[Abstract]
[Full Text]
-
Planaguma, J., Diaz-Fuertes, M., Gil-Moreno, A., Abal, M., Monge, M., Garcia, A., Baro, T., Thomson, T. M., Xercavins, J., Alameda, F., Reventos, J.
(2004). A Differential Gene Expression Profile Reveals Overexpression of RUNX1/AML1 in Invasive Endometrioid Carcinoma. Cancer Res.
64: 8846-8853
[Abstract]
[Full Text]
-
Cho, J.-Y., Akbarali, Y., Zerbini, L. F., Gu, X., Boltax, J., Wang, Y., Oettgen, P., Zhang, D.-E., Libermann, T. A.
(2004). Isoforms of the Ets Transcription Factor NERF/ELF-2 Physically Interact with AML1 and Mediate Opposing Effects on AML1-mediated Transcription of the B Cell-specific blk Gene. J. Biol. Chem.
279: 19512-19522
[Abstract]
[Full Text]
-
Suico, M. A., Yoshida, H., Seki, Y., Uchikawa, T., Lu, Z., Shuto, T., Matsuzaki, K., Nakao, M., Li, J.-D., Kai, H.
(2004). Myeloid Elf-1-like Factor, an ETS Transcription Factor, Up-regulates Lysozyme Transcription in Epithelial Cells through Interaction with Promyelocytic Leukemia Protein. J. Biol. Chem.
279: 19091-19098
[Abstract]
[Full Text]
-
Muller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Kohler, G., Stelljes, M., Puccetti, E., Ruthardt, M., deVos, S., Hiebert, S. W., Koeffler, H. P., Berdel, W. E., Serve, H.
(2004). Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells. Mol. Cell. Biol.
24: 2890-2904
[Abstract]
[Full Text]
-
Li, F.-Q., Person, R. E., Takemaru, K.-I., Williams, K., Meade-White, K., Ozsahin, A. H., Gungor, T., Moon, R. T., Horwitz, M.
(2004). Lymphoid Enhancer Factor-1 Links Two Hereditary Leukemia Syndromes through Core-binding Factor {alpha} Regulation of ELA2. J. Biol. Chem.
279: 2873-2884
[Abstract]
[Full Text]
-
Park, D. J., Vuong, P. T., de Vos, S., Douer, D., Koeffler, H. P.
(2003). Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays. Blood
102: 3727-3736
[Abstract]
[Full Text]
-
Steffen, B., Serve, H., Berdel, W. E., Agrawal, S., Linggi, B., Buchner, T., Hiebert, S. W., Muller-Tidow, C.
(2003). Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia. Proc. Natl. Acad. Sci. USA
100: 8448-8453
[Abstract]
[Full Text]
-
Vangala, R. K., Heiss-Neumann, M. S., Rangatia, J. S., Singh, S. M., Schoch, C., Tenen, D. G., Hiddemann, W., Behre, G.
(2003). The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood
101: 270-277
[Abstract]
[Full Text]
-
Schwieger, M., Lohler, J., Friel, J., Scheller, M., Horak, I., Stocking, C.
(2002). AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency. JEM
196: 1227-1240
[Abstract]
[Full Text]
-
Melnick, A., Carlile, G. W., McConnell, M. J., Polinger, A., Hiebert, S. W., Licht, J. D.
(2000). AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein. Blood
96: 3939-3947
[Abstract]
[Full Text]
-
Potter, M. D., Buijs, A., Kreider, B., van Rompaey, L., Grosveld, G. C.
(2000). Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6. Blood
95: 3341-3348
[Abstract]
[Full Text]
-
Strom, D. K., Nip, J., Westendorf, J. J., Linggi, B., Lutterbach, B., Downing, J. R., Lenny, N., Hiebert, S. W.
(2000). Expression of the AML-1 Oncogene Shortens the G1 Phase of the Cell Cycle. J. Biol. Chem.
275: 3438-3445
[Abstract]
[Full Text]
-
Goetz, T. L., Gu, T.-L., Speck, N. A., Graves, B. J.
(2000). Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor alpha 2. Mol. Cell. Biol.
20: 81-90
[Abstract]
[Full Text]
-
Jakubowiak, A., Pouponnot, C., Berguido, F., Frank, R., Mao, S., Massague, J., Nimer, S. D.
(2000). Inhibition of the Transforming Growth Factor beta 1 Signaling Pathway by the AML1/ETO Leukemia-associated Fusion Protein. J. Biol. Chem.
275: 40282-40287
[Abstract]
[Full Text]
-
Hildebrand, D., Tiefenbach, J., Heinzel, T., Grez, M., Maurer, A. B.
(2001). Multiple Regions of ETO Cooperate in Transcriptional Repression. J. Biol. Chem.
276: 9889-9895
[Abstract]
[Full Text]
-
Miyazaki, Y., Boccuni, P., Mao, S., Zhang, J., Erdjument-Bromage, H., Tempst, P., Kiyokawa, H., Nimer, S. D.
(2001). Cyclin A-dependent Phosphorylation of the ETS-related Protein, MEF, Restricts Its Activity to the G1 Phase of the Cell Cycle. J. Biol. Chem.
276: 40528-40536
[Abstract]
[Full Text]